HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James B Kahn Selected Research

Levofloxacin (Levaquin)

6/2010Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitis.
1/2008A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis.
11/2007A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis.
1/2007Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis.
12/2006Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients.
10/2006Comparison of the adverse event profiles of levofloxacin 500 mg and 750 mg in clinical trials for the treatment of respiratory infections.
8/2006Levofloxacin 750 mg QD for five days versus amoxicillin/clavulanate 875 mg/125 mg BID for ten days for treatment of acute bacterial exacerbation of chronic bronchitis: a post hoc analysis of data from severely ill patients.
7/2005Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
4/2004Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens.
9/2003High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James B Kahn Research Topics

Disease

5Infections
08/2009 - 02/2003
5Pneumonia (Pneumonitis)
12/2006 - 08/2002
3Prostatitis
06/2010 - 09/2003
3Urinary Tract Infections (Urinary Tract Infection)
01/2008 - 10/2007
3Pyelonephritis
01/2008 - 10/2007
2Healthcare-Associated Pneumonia
07/2007 - 02/2003
2Fever (Fevers)
12/2006 - 04/2004
2Chronic Bronchitis
10/2006 - 08/2006
1Staphylococcal Pneumonia
08/2009
1Maxillary Sinusitis
01/2007
1Sinusitis
10/2006
1Respiratory Tract Infections (Respiratory Tract Infection)
10/2006
1Cough
08/2006
1Bacteremia
08/2002

Drug/Important Bio-Agent (IBA)

13Levofloxacin (Levaquin)FDA Link
06/2010 - 08/2002
5Ciprofloxacin (Cipro)FDA LinkGeneric
01/2008 - 02/2003
4Pharmaceutical PreparationsIBA
08/2009 - 02/2003
3FluoroquinolonesIBA
10/2007 - 02/2003
2ceftobiproleIBA
08/2009 - 07/2007
1Cephalosporins (Cephalosporin Antibiotics)IBA
07/2007
1Amoxicillin (Wymox)FDA LinkGeneric
08/2006
1Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric
08/2006
1Prostate-Specific Antigen (Semenogelase)IBA
07/2005
1Anti-Bacterial Agents (Antibiotics)IBA
07/2003
1Anti-Infective Agents (Microbicides)IBA
02/2003
1Imipenem Drug Combination Cilastatin (Primaxin)FDA Link
02/2003
1MacrolidesIBA
08/2002
1Azithromycin (Zithromax)FDA LinkGeneric
08/2002
1Ceftriaxone (Ceftriaxon)FDA LinkGeneric
08/2002

Therapy/Procedure

7Therapeutics
06/2010 - 02/2003
1Catheters
01/2007